Literature DB >> 16382272

Iliofemoral venous pressure correlates with intraabdominal pressure in morbidly obese patients.

Berndt Arfvidsson1, Bo Eklof, John Balfour.   

Abstract

Clinically, it has been observed that severely and morbidly obese individuals more often have venous leg symptoms related to venous stasis than normal-weight persons have. Obesity is associated with an increased intraabdominal pressure (IAP). The increased IAP in severely and morbidly obese patients would reasonably cause an elevated iliofemoral venous pressure (IFVP), which transmits via incompetent femoral veins, causing venous stasis in the lower limbs. The aim of this study was to determine whether the elevated IAP assessed by the urinary bladder pressure (UBP) corresponded with an increased directly measured IFVP. Fifteen women with morbid obesity were investigated with simultaneous UBP and direct iliofemoral vein pressures. Four normal-weight controls were investigated in the same manner. The obese patients had significantly higher UBP than the controls had, 19.1 and 8.5 cm H2O, respectively. They also had elevated IFVP compared with the controls, 19.7 and 7.5 cm H2O, respectively, and these IFVPs correlated well with the UBPs. The assumption that increased IAP in morbidly obese patients causes increased IFVP was consequently determined. To our knowledge, this has not previously been demonstrated in human individuals. How these elevated pressures contribute to the development of lower limb venous insufficiency is subject to further studies.

Entities:  

Mesh:

Year:  2005        PMID: 16382272     DOI: 10.1177/153857440503900607

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  8 in total

1.  Introduction of 2-octyl cyanoacrylate (Dermabond®) for incisional hernia mesh repair.

Authors:  Yoshiyuki Saito; Keisuke Kubota; Akihiro Okada; Tomoaki Deguchi; Junko Kuroda; Nobuhiro Nitori; Tomohisa Kadomura; Masashi Yoshida; Masaki Kitajima
Journal:  Surg Today       Date:  2015-04-10       Impact factor: 2.549

2.  Does femoral venous pressure measurement correlate well with intrabladder pressure measurement? A multicenter observational trial.

Authors:  Bart L De Keulenaer; Adrian Regli; Wojciech Dabrowski; Vaxtang Kaloiani; Zsolt Bodnar; Javier Izura Cea; A Andrey Litvin; Wendy A Davis; Anne-Marie Palermo; Jan J De Waele; Manu L L N G Malbrain
Journal:  Intensive Care Med       Date:  2011-07-08       Impact factor: 17.440

3.  [Ulcers in obesity-associated chronic venous insufficiency].

Authors:  L Scholl; M Dörler; M Stücker
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

4.  Diurnal changes of lower leg volume in obese and non-obese subjects.

Authors:  R P Engelberger; A Indermühle; F Baumann; J Fahrni; N Diehm; N Kucher; U Egermann; K Laederach; I Baumgartner; T Willenberg
Journal:  Int J Obes (Lond)       Date:  2013-09-13       Impact factor: 5.095

Review 5.  What is normal intra-abdominal pressure and how is it affected by positioning, body mass and positive end-expiratory pressure?

Authors:  B L De Keulenaer; J J De Waele; B Powell; M L N G Malbrain
Journal:  Intensive Care Med       Date:  2009-02-26       Impact factor: 17.440

6.  Analysis of the Common Femoral Artery and Vein: Anatomical Morphology, Vessel Relationship, and Factors Affecting Vessel Size.

Authors:  Sang-Hun Lee; Dong Uk Yu; Tae Kwon Kim; Jae-Cheon Jeon; Sang Chan Jin; Woo Ik Choi; Jae Ho Lee
Journal:  Medicina (Kaunas)       Date:  2022-02-21       Impact factor: 2.430

7.  Impact of weight loss due to sleeve gastrectomy on shear stress of the femoral vein in morbid obesity.

Authors:  Maciej Wiewiora; Jerzy Piecuch; Marek Glück; Ludmila Slowinska-Lozynska; Krystyn Sosada
Journal:  Obes Surg       Date:  2014-05       Impact factor: 4.129

8.  Theoretical Analysis of the Relative Impact of Obesity on Hemodynamic Stability During Acute Hemorrhagic Shock.

Authors:  Sarah A Sterling; Alan E Jones; Thomas G Coleman; Richard L Summers
Journal:  Arch Trauma Res       Date:  2015-09-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.